X-Linked Combined Immunodeficiency Diseases
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases
|
Disease or Syndrome
|
38
|
42
|
0.040 |
None |
1.000 |
4 |
|
2005 |
2016 |
WAGR Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Eye Diseases; Male Urogenital Diseases; Nervous System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
13
|
11
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Undifferentiated leukemia
|
disease |
|
Neoplastic Process
|
120
|
2
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2020 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Thymoma
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
291
|
20
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Teratocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
141
|
1
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Tendinopathy
|
disease |
Musculoskeletal Diseases; Wounds and Injuries
|
Disease or Syndrome
|
80
|
16
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Solid Neoplasm
|
phenotype |
Neoplasms
|
Neoplastic Process
|
1145
|
24
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Retinoblastoma
|
disease |
Neoplasms; Eye Diseases
|
Neoplastic Process
|
853
|
193
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Red Blood Cell Count measurement
|
phenotype |
|
Laboratory Procedure
|
717
|
1599
|
0.100 |
None |
1.000 |
2 |
1
|
2016 |
2019 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.030 |
None |
1.000 |
3 |
|
2007 |
2018 |
Progression of prostate cancer
|
disease |
|
Neoplastic Process
|
398
|
7
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.090 |
None |
1.000 |
9 |
|
1997 |
2019 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
644
|
23
|
0.400 |
None |
0.970 |
33 |
|
1992 |
2019 |
Precursor cell lymphoblastic lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
88
|
4
|
0.010 |
None |
1.000 |
1 |
|
1992 |
1992 |
Precursor Cell Lymphoblastic Leukemia Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
879
|
168
|
0.030 |
None |
1.000 |
3 |
|
1992 |
2019 |
Precursor B-cell lymphoblastic leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
478
|
23
|
0.030 |
None |
0.667 |
3 |
|
2010 |
2011 |
Pancreatic intraepithelial neoplasia
|
disease |
Neoplasms
|
Neoplastic Process
|
186
|
11
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Pancreatic carcinoma
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
2689
|
322
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Nephroblastoma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
586
|
125
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
18 |
|
1991 |
2018 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2017 |
Myeloid Leukemia, Chronic
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1172
|
115
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |